Chanyue Zhao
Hunan Key Laboratory Of Kidney Disease And Blood Purification
Changsha, China
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
GSTK1 and RETREG1/FAM134B-mediated reticulophagy attenuates tubular injury in diabetic nephropathy through endoplasmic reticulum stress and apoptosis.
Journal: Autophagy
Published: August 08, 2025
PACS-2 deficiency aggravates tubular injury in diabetic kidney disease by inhibiting ER-phagy.
Journal: Cell death & disease
Published: January 26, 2023
GBP2 promotes M1 macrophage polarization by activating the notch1 signaling pathway in diabetic nephropathy.
Journal: Frontiers in immunology
Published: December 19, 2022
β-Hydroxybutyrate against Cisplatin-Induced acute kidney injury via inhibiting NLRP3 inflammasome and oxidative stress.
Journal: International immunopharmacology
Published: May 04, 2022
PACS-2 deficiency in tubular cells aggravates lipid-related kidney injury in diabetic kidney disease.
Journal: Molecular medicine (Cambridge, Mass.)
Published: April 13, 2022
Using network pharmacology to explore the mechanism of Danggui-Shaoyao-San in the treatment of diabetic kidney disease.
Journal: Frontiers in pharmacology
Published: January 12, 2022
PACS-2 Ameliorates Tubular Injury by Facilitating Endoplasmic Reticulum-Mitochondria Contact and Mitophagy in Diabetic Nephropathy.
Journal: Diabetes
Published: November 02, 2021
Caveolin-1 Regulates Cellular Metabolism: A Potential Therapeutic Target in Kidney Disease.
Journal: Frontiers in pharmacology
Published: August 31, 2021
DsbA-L Ameliorates Renal Injury Through the AMPK/NLRP3 Inflammasome Signaling Pathway in Diabetic Nephropathy.
Journal: Frontiers in physiology
Published: January 28, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026